Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stocks, par value $0,0001 per share
-
Shares outstanding
-
58.5M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
15.7M
-
Shares change
-
+15.7M
-
Total reported value, excl. options
-
$530M
-
Value change
-
+$530M
-
Number of buys
-
52
-
Price
-
$34.01
Significant Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q4 2020
53 filings reported holding BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share as of Q4 2020.
BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.7M shares
of 58.5M outstanding shares and own 26.75% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (3.18M shares), Cormorant Asset Management, LP (2.29M shares), FARALLON CAPITAL MANAGEMENT LLC (1.97M shares), FMR LLC (1.78M shares), JANUS HENDERSON GROUP PLC (1.32M shares), BAKER BROS. ADVISORS LP (825K shares), BOXER CAPITAL, LLC (686K shares), PRICE T ROWE ASSOCIATES INC /MD/ (638K shares), WELLINGTON MANAGEMENT GROUP LLP (597K shares), and MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (500K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.